Trending
April 9, 2024 Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management TeamApril 5, 2024 PanTher Therapeutics Appoints John Edwards as Executive Chair of the Board of DirectorsMarch 26, 2024 StatLab Medical Products Acquires Poly Scientific R&DMarch 26, 2024 Healthcare Advisory Firm Coker Group Sells Majority Stake to PE Firm Trinity Hunt PartnersMarch 22, 2024 Dr. Michael Jellinek and Dr. Courtney Phillips Join Oceans Healthcare’s Board of Directors
Featured
April 9, 2024
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage... Read more »
April 5, 2024
PanTher Therapeutics Appoints John Edwards as Executive Chair of the Board of Directors
AUSTIN, Texas--(BUSINESS WIRE)--PanTher Therapeutics, a clinical-stage oncology company developing high-dose, long... Read more »
March 26, 2024
StatLab Medical Products Acquires Poly Scientific R&D
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, a leading developer and manufacturer of medical diagnostic... Read more »
April 10, 2024
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
March 26, 2024
Healthcare Advisory Firm Coker Group Sells Majority Stake to PE Firm Trinity Hunt Partners
